Transcriptional repressors controlling the expression of cytokine genes have been implicated in a variety of physiological and pathological phenomena. An unknown repressor that binds to the distal NFAT element of the interleukin-2 (IL-2) gene promoter in naive T-helper lymphocytes has been implicated in autoimmune phenomena and has emerged as a potentially important factor controlling the latency of HIV-1. The aim of this paper was the identification of this repressor. We resorted to public microarray databases looking for DNA-binding proteins that are present in naïve resting T cells but are downregulated when the cells are activated. A Bayesian data mining statistical analysis uncovered 25 candidate factors. Of the 25, NFAT4 and the oncogene ets-2 bind to the common motif AAGGAG found in the HIV-1 LTR and IL-2 probes. Ets-2 binding site contains the three G's that have been shown to be important for binding of the unknown factor; hence, we considered it the likeliest candidate. Electrophoretic mobility shift assays confirmed cross-reactivity between the unknown repressor and anti-ets-2 antibodies, and cotransfection experiments demonstrated the direct involvement of Ets-2 in silencing the IL-2 promoter. Designing experiments for transcription factor analysis using microarrays and Bayesian statistical methodologies provides a novel way toward elucidation of gene control networks.
Introduction
T-helper (CD4) cells are important for a healthy immune response and their role is central in the pathogenesis of autoimmune diseases. Modification of T-helper cell function by immunosuppressive drugs is important in organ replacement therapy through transplantation. On the other hand, depletion of T-helper lymphocytes during the course of HIV infection leads to immune system failure that manifests itself with opportunistic infections, malignancies and even autoimmune phenomena. Thus T-helper effector functions are important in both health and disease and these functions are evident when T cells are activated.
The activation of T lymphocytes begins with the engagement of the T-cell receptor (TCR). 1 The naive CD4 T cell requires high-density, 2,3 sustained 4 TCR signaling involving crosslinking of the TCR to initiate any response. Post-receptor events after TCR engagement lead to the activation and nuclear translocation of a number of transcription factors (TFs) including nuclear factor of activated T cells (NFAT); NFAT activity regulates the transactivation of a number of cytokine and other genes, including interleukin-2 (IL-2), [5] [6] [7] IL-3, 8 IL-4, [9] [10] [11] tumor necrosis factor-a 12, 13 and granulocyte-macrophage colony stimulating factor 14, 15 through consensus binding sites present in the promoter of the corresponding genes.
The response of HIV-1 to host cell activation is strikingly similar to that of the IL-2 gene, which, in the T-cell leukemia Jurkat, is controlled by NFAT through the distal PRRE 7 element of the HIV-1 virus. For this reason, the HIV-1 PRRE (positions À279 to À250), and the adjacent NFAT motif (positions À252 to À216) are often considered as putative response elements to T-cell activation. Attempts to prove functionally the involvement of PRRE and NFAT sites in HIV-1 activation gave contrasting results, 16, 17 indicative of a dual negative and positive role. Transactivation studies of the IL-2 promoter in the Xenopus oocyte system 18 with protein extracts from ex vivo isolated T lymphocytes revealed several novel aspects of IL-2 regulation. The IL-2 promoter is repressed by proteins from resting naïve CD4 cells. This repressor acts through the distal IL-2 PRRE that is also the NFAT binding site. Following T-cell activation, the repressor disappears and an activator is de novo synthesized. [18] [19] [20] These findings prompted the reinvestigation 21 of HIV-1 LTR regulation by functional transactivation assays using proteins from primary T cells (isolated from cord blood or peripheral blood) proving that the HIV-1 LTR is regulated in a similar manner to the IL-2 promoter. Since the protein binding to the aforementioned repressor sequence exists only in CD4 resting naive T cells of both human and mouse origin, it is probably a key molecule for the immune system, and one potentially important for the pathogenesis of certain autoimmune diseases.
Given these findings, we opted to identify the unknown repressor by resorting to public gene expression databases looking for DNA-binding proteins that quantitatively behaved similar to the unknown molecule. From an experimental perspective, the problem we are trying to solve is a well posed one: we are looking for DNA-binding proteins that are present in naïve T cells but are downregulated when the cells are activated. In addition to this functional requirement, such proteins should bind to the PRRE of the IL-2 promoter and the HIV-1 LTR and also to 'mutant' probes, in accordance with previous findings. Hence the available background information suggests a two-step experimental design: (1) candidates are identified in gene expression (ie microarray) databases, (2) antibodies against the corresponding proteins are tested in properly controlled electrophoretic mobility shift assays (EMSA), and (3) the functional role of the protein(s) identified is established through cotransfection experiments.
A statistically rigorous treatment of available public gene expression databases on T lymphocytes was undertaken to avoid many of the methodological data analysis caveats that seem to plague microarray data analysis in general. The usual simple k-fold-like approach, which dominates the literature, is fraught with theoretical and practical problems. At very low expression levels, the expression ratio can become undefined due to low signal to noise ratio; at the other end of the range, saturation phenomena are prominent. Hence the k-fold approach misses important differences, while leading to unacceptably high false-positive rates compared to statistical techniques involving hypothesis testing. [22] [23] [24] The Bayesian solution (see Appendix at the end of this paper) to this problem is applied for the first time in the microarray literature and shown to possess desirable properties in this application domain. Such features include but are not limited to: (a) complete summary of available information on the basis of a single numerical measure for each gene of interest, the posterior odds ratio (POR), (b) differential support for hypothesis testing (also known as 'not all significant findings are equally significant'), and (c) explicit and consistent treatment of sample size limitations and measurement (ie fluorescent channel) error heteroscedasticity. These features enabled us to sort potential candidate genes that are downregulated upon T-cell activation in descending order according to their POR and then give priority testing to those with binding sites closest to the common motif AGGAAG contained in the HIV-1 LTR and IL-2 probes.
The functional involvement of this repressor protein in autoimmunity is suggested by its absence from the nuclei of resting T cells isolated from autoimmune patients. 25 De-repression of the HIV-1 LTR and the IL-2 gene could provide an additional trigger for viral activation and at the same time explain the multitude of autoimmune phenomena observed during disease progression.
Results

Differential gene expression assessed by Bayesian methods
Bayesian analysis of differential gene expression proceeded as detailed in materials and methods. By setting an (arbitrary) cutoff POR (cf Materials and methods) equal to 20 for differential gene expression, we can graphically portrait the results of the statistical analysis using a scatterplot (Figure 1) . Genes considered to be downregulated (POR420) are shown in green, whereas genes considered to be up-regulated are marked with red spots. Note that a great number of genes that would be called differentially expressed on the basis of a two-fold change difference in expression (ie those falling below the dotted lines in Figure 1 ), are not considered to be so, when viewed from a statistical perspective. On the other hand, subtle changes were detected (the majority of 'significant' calls fall between the dotted lines that mark the two-fold change region). This finding is especially noteworthy considering that the gene expression profile was generated after only 3 h of mitogenic stimulation, before the new steady-state expression profile has been attained.
Identification of transcription factors downregulated upon T-cell activation
To identify potential candidates for further EMSA experiments, we sorted the 'significant' calls from the previous step in order of descending POR. Scanning through the list of downregulated genes in order of descending POR, we selected those that corresponded to known TFs. The results are tabulated in Table 1 (identity of TFs with associated POR) and 2 (TF and consensus binding motifs determined from the TRANSFAC Database Public Release 5.0 and PubMed literature searches). We used the POR as a semiquantitative measure of the likelihood of a TF being the repressor we are looking for. Figure 1 Graphical representation of the results of Bayesian statistical analysis on the T-cell activation data set. X-axis, gene expression in naïve CD4 T cells (CD4 þ naïve); Y-axis, gene expression in CD4 T cells activated with the mitogens PMA and ionomycin (CD4 þ I þ P). Expression levels measured in log scale after median normalization. The two dotted lines correspond to a two-fold repression (lower line) or induction (upper line). Green dots, genes that are 420 times more likely to be downregulated than upregulated; red dots, genes that are more likely to be upregulated; black dots, genes that are neither upregulated nor downregulated.
We selected the factors to be used for the experiments on the basis of (a) high PORs and (b) similarity of their binding sites to the common motifs in the IL-2 and HIV-1 PRRE.
In Table 1 , we summarize the factors found to be downregulated during T-cell activation, presented in descending POR order. We also tabulated the average baseline expression prior to activation, and the corresponding fold change in linear and log space. Note that even small changes are detected irrespective of the baseline expression level. Table 2 lists available information apropos the binding site of the identified TFs (downloaded from TRANSFAC PR 5.0 Database). Factors that bind to elements with high structural similarity to the target sequences (HIV-1, IL-2 PRRE) are highlighted in bold (ie NFAT4, ets-2), whereas another three factors (Ikaros, STAT1, interferon-stimulated transcription factor 3) bind to sequences that are less similar to the aforementioned target sequences. The rest of the factors either bind to irrelevant or unknown sequences.
Tentative identification of the IL-2 repressor by depletion EMSA experiments To identify the unknown repressor, we designed depletion EMSA experiments, based on the findings of the Bayesian data analysis and the TRANSFAC database search. We focused on the two factors that had a high likelihood of being the repressor on the basis of functional (ie microarrays) and molecular recognition (ie binding site) data. Since the repressor has been shown to be a relatively small protein (ca 50-60 kDa), and the ets-2 binding site contains the three G's that are important for the binding of the repressor, we chose to test ets-2 first, rather than NFAT4 which has a much larger molecular weight. A variety of antibodies against other TFs were used as controls to assess specificity of depletion. The corresponding TFs (c-fos p62, fos-B, fra-1, fra-2 p46, c-jun p 49, jun-B p 39, jun-D p 39, NFkB p65, NFkB p50, c-rel p 75, p53 tumor suppressor proteins) have been shown either not to interact with the oligonucleotide probe or to be absent from unstimulated T cells. Depletion of all these factors failed to cause a significant reduction in the intensity of the band in the EMSA experiment ( Figure 2 ). On the other hand, use of anti-ets-1 and even more so anti-ets-1/2 antibodies resulted in a decrease of the migrating complex of repressor-oligonucleotide, suggesting that the relevant protein shares extensive structural similarity to the protein ets-2.
Repression of IL-20-promoter-derived elements by ETS-2
To further establish the functional role of the ETS-2 gene in the function of IL-2-promoter-derived elements, we cotransfected an ets-2 expression vector, with reporter genes driven by elements of the IL-2 promoter; a CMV promoter construct was used as control (Figure 3a-d) . The first experiment (utilizing the À326 to þ 45 region of the IL-2 promoter) demonstrated a dose-dependent reduction of a reporter gene (luciferace) when varying amounts of ETS-2 plasmid were cotransfected. Absolute reduction in luciferace activity, expressed as a percentage of the activity of IL-2/control plasmid (vector alone) cotransfection, ranged from 25 to 45% as the amount of POR, posterior odds ratio. In case of multiple probes interrogating the same factor (eg Id2), the posterior probabilities were averaged and then converted to a POR. Baseline, baseline expression in log scale (negative values correspond to genes with expression less than the median value in the data set). D Fold (Log), difference in expression expressed in log scale; D Fold, difference in expression expressed as a before/after stimulation ratio.
Mining microarray data for unknown repressor C Argyropoulos et al ETS-2 plasmid was increased from 5 to 20 mg per 8 Â 10 6 cells transected (cf Figure 3a) . Similar reduction percentages were acheived when a different construct featuring the IL-2 PRRE (three copies of the distal NFAT binding site containing 5 0 IL-2 sequences À285 to À255) driving the expression of CAT (chloramphenicol acetyl transferase) was utilized. Absolute reduction in CAT activity (measured as % conversion of chloramphenicol to the acetylated forms) ranged from 25 to 89% (cf Figures 3b  and d) . Repetition of the experiments using a different target (the CMV promoter driving the expression of CAT) failed to show a similar dose-dependent reduction; actually, cotransfection of ETS-2 with CMV-CAT enhanced the expression of the latter (cf Figure 3c) .
Discussion
DNA gene expression microarrays allow biologists to study genome-wide patterns of gene expression. Microarray expression analysis offers an opportunity to generate functional data on a genome-wide scale and consequently, should provide much-needed data for the biological interpretation of genes and their functions. 26 A common task is to compare the expression levels of genes in samples drawn from two different tissues or at two different time points or conditions. Specifically, it is of interest to detect genes with differential expression under the two conditions. In early days, the simple method of fold changes was used, but it is now known to be unreliable 27 because statistical variability was not taken into account. Since then, many more sophisticated statistical methods have been proposed. 23, [27] [28] [29] Critical issues that the aforementioned attempts try to address, with variable success, include the small sample typical of Depletion EMSA experiments with antibodies against cfos p62, fos-B, fra-1, fra-2 p46, c-jun p49, jun-B p39, jun-D p39, NFkB p65, NFkB p50, c-rel p75, ets-1 p54, polyclonal anti-ets1/ets-2 and p53 tumor suppressor proteins. Nuclear extracts from PBMCs (unstimulated) were depleted from the corresponding TFs and subsequently used in EMSA experiments against the oligonucleotide HIV-1 PRRE. The antibodies against factors ETS1 and ETS 1/2 seem to deplete the unknown factor, whereas none of the other antibodies employed led to a significant decrease the band radioactivity. Since the polyclonal anti-ETS1/2 was more effective than the pure anti-ETS1 antibody, we interpret the EMSA findings as consistent with the hypothesis that the unknown repressor shares extensive immunoreactivity and should be tentatively identified with the protein ETS-2.
Mining microarray data for unknown repressor C Argyropoulos et al microarray experiments and the very large number of comparisons involved. Typically one is forced to manipulate the significance level (ie Bonferroni corrections) 30 and subsequently validate a fraction of these (reduced) hits by some other method. Although various ad hoc have been proposed for the former, no roadmap exists as to how many and which findings one should independently validate. 31 Bayesian theory uniquely addresses these three issues by providing a formal quantitative framework to coherent reasoning and decision-making in situations of uncertainty. Within this theory, the problem of comparing two samples has a well-defined solution, and this solution holds even when the only available information comes from extremely small samples. 32, 33 Evaluating the probability that a given hypothesis is correct produces a numerical measure (POR) that can be used to design an experiment to corroborate or refute the original hypothesis. A question that naturally suggests itself, is how sensitive the results are to the assumptions of the Bayesian analysis. The assumptions made in the current analysis are that of normality of microarray measurements and the setting of cutoff for the POR; the prior used (Appendix) does not make any assumptions on the relationship among the parameters (ie average expression levels, and their dispersions) for the resting and the activated state, which is precisely the reason it is advocated when such assumptions would be questionable. In the statistical literature it is established that a test based on the BehrensFisher (BF) distribution is robust with respect to departures from normality. 32, 34, 35 Violations of normality can impact subsequent analysis by leading to false-positive results or false-negative ones; the conservative nature of the BF test guards against the former, whereas judicial selection of the POR threshold can help minimize the latter. In situations involving comparisons between small samples, typical of current microarray research, the normality assumption is a reasonable compromise since any other (nonparametric) approach would be of limited power to detect differences and other parametric approaches would require larger data sets and extensive numerical experimentations. Our analysis does not depend on the absolute value of the POR for the genes examined; we used the POR only to sort genes and although we would expect PORs to be different under a non-normal statistical model, the relative order of the 'true' POR would probably be not much different from the one obtained assuming normality.
Maximizing the expected utility of the experimental validation step involves the combination of the POR Figure 3 Inhibitory role of ETS-2 on IL-2-promoter-derived elements driving reporter gene expression. A leukemic T-cell line (Jurkat) was cotransfected with DNA clones containing the ETS-2 coding region and IL-2-promoter-derived elements driving the expression of reporter genes. Subsequently, the cells were activated and the activity of the reporter gene was measured as a function of the quantity of ETS-2 construct utilized. All the experiments were performed in triplicates and reported as mean þ s.e.m. activity. measure with a similarity score between binding motifs of the candidate TFs. These features enabled us to sort potential candidates in descending order of significance, cutting down on the number of experiments that had to be performed prior to putative identification of the repressor protein. The similarity score can be a semiquantitative assessment as in the present study, or can be generated by any of the biological sequence scoring algorithms (ie profile HMMs). Note that the proposed methodology to transcriptional repressor identification is rather general and not limited to the specific locus examined. Turning to the 'most significant' findings of Table 1 (ie Id2 and NFAT4), we note that both of these factors have been shown to have an inhibitory role in the immune system of knockout transgenic animal models. [36] [37] [38] Our results from the depletion EMSA experiments and the transfection assays demonstrate a significant inhibitory potential for the ets-2 protein that binds to the distal NFAT element and represses the expression of IL-2-promoter elements. The fact that silencing could be experimentally demonstrated by transfection experiments carried out in mitogenically stimulated Jurkat cells, that is, a T-cell leukemia, attests to the repressing potential of ets-2 on the IL-2 promoter.
The TFs of the ets family control the expression and the differentiation of a wide variety of genes in hemopoietic cells. It is a rather ancient family of transcriptional regulators and tens of members from organisms as diverse as sponges and humans have been isolated. 39 All factors share a common DNA-binding motif, the ets domain, which has been shown to be a variation of the winged helix-turn-helix motif. 40 Ets-1 and other members of the same family make contacts with a 20 bp containing a central GGA motif (note that the IL-2 and HIV PRRE do contain such a motif). Ets-like proteins are expressed during development of the immune system; a comprehensive analysis of the expression of members of this family revealed striking dynamic patterns in all cells tested. 41 The functional involvement of this repressor in auto-immune phenomena is also suggested by EMSA experiments using nuclear extracts of lymphocytes from children with ITP, an autoimmune bleeding disorder characterized by immunologically mediated reduction in circulating platelet numbers. 25 In the aforementioned publication, a probe featuring the ets-2 consensus sequence AAGGAG was used to search for migrating complexes similar to the ones demonstrated in the present paper. No such complexes were found in patients with ITP compared to normal controls. The absence of the repressor during both disease activity and remission, suggests that this abnormality is primary, rather than an epiphenomenon. During lymphocyte maturation, a failure in the acquisition of the repressor by some otherwise mature thymocytes could result in an increased number of peripheral naive T cells, which are more prone to develop into autoreactive clones upon antigenic stimulation. Further studies should establish the exact involvement of ets-2 or other members of the ets family in the wide spectrum of autoimmune phenomena and, besides, investigate the role that all the 25 candidate TFs that were revealed from this analysis may play in autoimmune diseases.
Materials and methods
Data sources-the 'lymphochip' data set
The most comprehensive gene expression profiling studies of lymphocytes was generated by Alizadeh et al 42 during an attempt to characterize molecular prognostic markers for immune-related malignancies (non-Hodgkin's lymphomas). The data set comprised measurements of 17 853 gene probes constructed from various B-cell and T-cell cDNA libraries, and a variety of genes (mainly TFs) that had been shown to be expressed in cells of the immune system. The probe sequences had been deposited in GENBANK and were also available as plasmids -bacterial clones through the IMAGE consortium. 43 Pertinent to our work, a small part of the data set had assessed the gene profile changes due to T-cell activation using a common mRNA source as a reference for all experiments.
The raw data were downloaded from the Stanford Microarray Database 44 (genome-www.Stanford.edu/microarray) and stored in a relational database created in the freely available open source database management server MySQL (www.mysql.com).
The gene to probe mapping was not known for the majority of the probes at the time the data were generated by the original authors. Only 5161 probes had been unequivocally assigned to a known gene or a UniGene cluster when the data were deposited in the Stanford Microarray Database. To deal with this problem, we used the GenBank accession numbers present in the raw data to update this information. Briefly, a web agent (written in the freely available scripting language PERL www.perl.com) used the gene accession numbers to query UniGene over the internet. In essence, the web agent automated the task of retrieving web pages from UniGene (built in November 2001). The description line of the web page was captured by the agent and stored locally along with the corresponding accession number. This updated information was then loaded into the database. Eventually, we were able to resolve the probe to gene mapping for 10 521 genes.
Microarray data preprocessing A two-step statistical analysis methodology was adopted: an initial preprocessing phase, followed by a formal Bayesian comparison of gene expression profiles of CD4 resting naive vs CD4 activated T lymphocytes from the 'Lymphochip' data set (three hybridizations per group). During the initial phase, the local background of any given spot in the microarray image was estimated by averaging the values of the background of neighboring spots; if the median spot intensity was greater than the 99 percentile of the local background, then that spot was considered well-measured. To ensure that measurements from poor quality probes did not contaminate analysis, we imposed an extra criterion: we censored those probes that failed to give a reliable signal (any signal greater than the local background) in Z80% of all samples in the Lymphochip database. Since experimental variation (after statistical filtering, log-transform and global median normalization) from the reference channel was small (average CV less than 10%), we did not use a within-channel normalization scheme; the median expression level of the 'lymphocyte channel' was subtracted in log space, without any further processing.
Statistical data analysis
The second formal phase analyzed the gene expression profiles by adopting a Bayesian perspective. For the two sample case the problem is formally defined as a comparison between a control (resting naive CD4) and treatment (phorbol 12-myristate 13-acetate (PMA) and ionomycin-activated CD4 lymphocytes) group for differences in gene expression after activation. Such comparison takes place after we calculate the quantity: Statistical test: The BF distribution with n c ¼n t ¼2 degrees of freedom and gene-specific angle (cf Appendix).
Bayesian hypothesis testing: The POR is given by:
where Probability (downregulation) is the right tail area for the BF distribution (Appendix) for a given gene. Bayesian inference: It is based on the POR for every gene. The POR is a numerical measure, which summarizes the support the data lend in favor of the null hypothesis; the higher the POR measure, the more likely the corresponding gene to be downregulated than not (Appendix). A POR threshold essentially defines a region separating downregulated from upregulated and 'no-change' genes in a probabilistic manner (Appendix). POR calculations involve the evaluation of integrals of the BF distribution, and are accomplished using the mixed symbolic-numerical computer algebra system Mathematica. 46 Post-analytic validation After Bayesian data analysis, a list of genes was generated; the ones corresponding to known TFs or mapping to a UniGene cluster containing potential DNA-binding motifs were extracted for further processing. To further reduce the list, we tried to establish whether the DNA-binding proteins we had access to are known to bind to sequences similar to IL-2 PRRE/ HIV-PRRE. The TRANSFAC Database Public Release 5.0 47 was queried over the web and the DNA-binding motifs of the proteins were determined. In addition, targeted literature searches were undertaken to determine (1) whether the factors we pinpointed had been independently proposed to act as transcriptional repressors and (2) the structural basis of their DNA-binding function. The factor that seemed to be the repressor we are seeking on the basis of the extended biological information was selected for EMSA experiments. A formal presentation of the quantitative aspects of the selection process is given in Appendix.
Cells
Cord blood of healthy neonates was collected in heparinized tubes (Maternity Clinic, University Hospital of Patras and Maternity Clinic of St Andrew Hospital, Patras, Greece). Peripheral blood mononuclear cells (PBMCs) were prepared by centrifugation over a Ficoll-Paque gradient (Pharmacia, Upsalla, Sweden). The cells (10 6 PBMCs/group) were washed 4 Â with RPMI1640 culture medium (Gibco BRL, Gaithersburg, MD, USA), pelleted and stored as 'dry' pellet at À801C till further processing. Cells were used without furher purification since it had been previously established that the repressor is contained only in the naïve CD4 subset of PBMCs and that cord blood contains only naïve CD4 cells. For the transfection experiments, the T leukemia Jurkat was used.
Protein extraction from T cells Extracts were prepared from total cell lysates as described previously. 18 Briefly, cells were swollen in a hypotonic buffer, briefly sonicated, and salt was adjusted to 300 mM KCl to extract proteins from chromatin. After 20 min on ice, the lysate was spun (100 000 g for 1 h at 41C) and the supernatant collected on a buffer containing 20 mM HEPES, 0.02 mM EDTA, pH 7.6, 0.5 mM 1,4 dithio-DL-theitol (KIB). Protein concentration was determined with the Bradford Assay. Prior to EMSA, the protein extracts were precipitated in 10% w/v POLYETHELE-NEGLYCOL (PEG8000) with constant stirring for 20 min at 41C. The proteins were then centrifuged at 10 000 g for 20 min and the pellet was redisolved in KIB buffer. 25 EMSA depletion experiments Protein A sepharose (Amersham Biosciences, Buckinghamshire, UK) was prepared in 1:1 v/v in KIB buffer as initial step (PAS-KIB). In all, 10 ml of PAS-KIB was mixed with 10 ml of protein extract and incubated at 41C for 1 h. Subsequently, the reaction mix was centrifuged at 27 000 g and the supernatant was preincubated with 1 mg of TF-specific antibody at 41C for 1 h. Antibodies against the following TFs were used: c-fos p62, fos-B, fra-1, fra-2 p46, c-jun p 49, jun-B p 39, jun-D p 39, NFkB p65, NFkB p50, c-rel p 75, ets-1 p54, polyclonal anti-ets1/ets-2, p53 tumor suppressor proteins. All the antibodies were from Santa Cruz biotechnology Inc (Santa Cruz, CA, USA). The TF-depleted supernatants were used in EMSA experiments against the HIV-1/IL-2 PRRE probe: AGGCCAATGAAGGAGAGAACAACAGCTTT. The gels were scanned after overnight exposure using PhosphoImager plates. Corel Photo Paint (www.corel.-com) was used to add labels to the scanned images.
DNA clones
An ets-2 expression vector, the pcDNA3-ETS2, was generated by inserting a PCR-derived HindIII/BamHI fragment of a human ets-2 cDNA into a HindIII/BamHIdigested pcDNA3 plasmid (a gift from I Talianidis, IMBB, Crete, Greece). The primers for the ets-2 PCR were 5 0 -CCCAAGCTTGGCAGGATGAATGATTTCGG and 5 0 -CGGGATCCTCAGTCCTCCGTGTCG. The target genes were: (1) a reporter plasmid IL-2-LUC containing the human IL-2 promoter (base pairs À326 to þ 45) directing the transcription of the luciferase gene; (2) a plasmid NFAT-CAT with three copies of the NFAT binding site containing 5 0 IL-2 sequences À285 to À255 linked to IL-2-promoter sequences from À72 to þ 47 linked to the CAT gene; 48 and (3) plasmid CMV-CAT 49 was used as control.
Transfections
Jurkat cells were transfected by electroporation with a Gene Pulser (ECM399, BTX, San Diego, CA, USA) at 260 V/28 ms. In all, 8 Â 106 cells/point were mixed with 10 mg target DNA with or without 5, 10, 20 or 50 mg pcDNA3-ETS2, in 0.35 ml plain RPMI1640 in 0.4-cm-gap cuvettes. Following transfection, the cells were allowed to recover in RPMI1640 medium supplemented with 5% FCS, penicillin and streptomycin for 24 h in an incubator (371C, 5% CO 2 , humidified atmosphere) and were then stimulated with the mitogens ionomycin (1 mg/ml) and phorbol myristate acetate (PMA, 25 ng/ml) and were incubated for a further 24 h. Alternatively, 5 Â 10 6 Jurkat cells/point were transfected using 70 ml of a liposomal reagent (LipoTAXI, Stratagene, Cedar Creek, TX, USA) premixed with 25 mg of target DNA with or without 5, 10, 20 or 50 mg pcDNA3-ETS2 in 1 ml RPMI1640, incubated for 2 h, allowed to recover for a further 22 h in complete culture medium in an incubator, stimulated as above with mitogens and incubated for another 12 h.
Luciferase and CAT assays
Luciferase activity was determined in 30 ml cell lysates as relative light units using the TD 20/20 Luminometer. To monitor and control transfection efficiency, cells were cotransfected with 1 mg pRL-TK, which contains the herpes simplex virus thymidine kinase promoter region upstream of Renilla luciferase. Expression of Renilla luciferase was detected using the Dual-Luciferase reporter assay system (Promega, Madison, WI, USA). CAT assays were performed as described 50 using 40 ml cell lysates.
p(H 0 |E,I) (probability that a gene is downregulated given microarray measurements) and p(H 1 |E,I) (probability that a gene is not downregulated given microarray measurements).
The ratio of the two posterior probabilities gives the posterior odds (ie how more likely is the null hypothesis vs the alternative) and is called the POR. A ratio for exmaple of 20 implies that the null hypothesis is 20 times more likely than the alternative one. A POR threshold essentially defines a region separating downregulated from upregulated and 'no-change' genes in a probabilistic manner. This follows from the simple probability calculus relation: The calculation of the relevant posterior probabilities in the present situation is known as the two means or the BF problem. The latter, which represents the most common problem in applied statistics, 32 is concerned with the determination of hypothesis tests for comparing the means of two normally distributed populations. The original BF solution (known as the BF Distribution) is an exact solution that can be derived when one adopts a Bayesian perspective; in the frequentist viewpoint one is left with approximations, notably the Welch-Satterwaite test, 52 which would be inadequate for small sample sizes. 33 To find out the posterior probability of downregulation from the available data, one needs to calculate the right tail region of the BF distribution. In the analysis of the current data set, the prior used is the so-called reference prior, 53 which considers all possible values of y 1 , y 2 , (mean expression levels for a single gene in the resting and activated state) and s 1 , s 2 (dispersions of expression ratios) equally likely. The choice of this prior is motivated by the following:
1. it is the option that would have the least impact on the final results, 53 letting the data 'speak for themselves,' 2. lack of background data to guide the specification of informative priors for EST probes, 3. a convenient default option due to the number of comparisons made(410 000 in our case).
